Relative Value

There is not enough data to reliably calculate the relative value of BRA.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BRA Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
19
vs Industry
3
Median 3Y
60
Median 5Y
60
Industry
2.3
vs History
vs Industry
Median 3Y
-4
Median 5Y
-4
Industry
22.5
vs History
vs Industry
35
Median 3Y
-11.4
Median 5Y
-11.4
Industry
14.4
vs History
vs Industry
31
Median 3Y
-28
Median 5Y
-17.8
Industry
21.4
vs History
vs Industry
2
Median 3Y
-3.4
Median 5Y
-3.4
Industry
2.2
vs History
15
vs Industry
2
Median 3Y
99.8
Median 5Y
99.8
Industry
2.5
vs History
23
vs Industry
2
Median 3Y
106.6
Median 5Y
106.6
Industry
5.2
vs History
vs Industry
Median 3Y
-74.2
Median 5Y
-51.4
Industry
11.9
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9
Industry
16.8
vs History
vs Industry
25
Median 3Y
-19
Median 5Y
-17.2
Industry
14.5
vs History
vs Industry
26
Median 3Y
-19
Median 5Y
-17.2
Industry
18.6
vs History
0
vs Industry
42
Median 3Y
1.7
Median 5Y
1.6
Industry
1.9

Multiples Across Competitors

BRA Competitors Multiples
Braster SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
PL
Braster SA
WSE:BRA
17m PLN 60 -4 -74.2 -9
US
Abbott Laboratories
NYSE:ABT
222.2B USD 5.1 15.9 20.3 28.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
212.5B USD 22.1 77.4 59.4 72.5
US
Boston Scientific Corp
NYSE:BSX
145B USD 7.5 51.9 30.3 41.2
US
Stryker Corp
NYSE:SYK
140.1B USD 5.7 47.6 23.2 28.1
IE
Medtronic PLC
NYSE:MDT
128.6B USD 3.7 27 15.1 21.9
DE
Siemens Healthineers AG
XETRA:SHL
51.7B EUR 2.2 24.1 13.6 19.1
US
Becton Dickinson and Co
NYSE:BDX
58.6B USD 2.7 34.9 12.8 21.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
56.5B USD 13.6 55 39.5 43.8
US
Edwards Lifesciences Corp
NYSE:EW
49.9B USD 8.5 36.4 26.1 28.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.5B USD 2 17.8 13.2 16
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
PL
B
Braster SA
WSE:BRA
Average EV/EBITDA: 25.4
Negative Multiple: -74.2
N/A N/A
US
Abbott Laboratories
NYSE:ABT
20.3
12%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
59.4
26%
2.3
US
Boston Scientific Corp
NYSE:BSX
30.3
22%
1.4
US
Stryker Corp
NYSE:SYK
23.2
13%
1.8
IE
Medtronic PLC
NYSE:MDT
15.1
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
13.6
11%
1.2
US
Becton Dickinson and Co
NYSE:BDX
12.8
9%
1.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.5
14%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
26.1
13%
2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
13.2
10%
1.3